These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22573342)

  • 21. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.
    Ou YQ; Zhu Wb; Li Y; Qiu PX; Huang YJ; Xie J; He SM; Zheng XK; Leng TD; Xu D; Yan GM
    Acta Pharmacol Sin; 2010 Jan; 31(1):73-80. PubMed ID: 19966835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
    Avan A; Quint K; Nicolini F; Funel N; Frampton AE; Maftouh M; Pelliccioni S; Schuurhuis GJ; Peters GJ; Giovannetti E
    Curr Pharm Des; 2013; 19(5):940-50. PubMed ID: 22973962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X; Liu S; Kleeff J; Friess H; Büchler MW
    Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
    Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD
    Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells.
    Dong J; Zhao YP; Zhou L; Zhang TP; Chen G
    Arch Med Res; 2011 Jan; 42(1):8-14. PubMed ID: 21376256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
    Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
    Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.
    Yang J; Ouyang J; Ouyang L; Ouyang L; Chen Y
    Oncol Res; 2013; 21(1):43-50. PubMed ID: 24330851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.
    Yao J; Qian C
    Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.
    Zheng T; Wang J; Chen X; Meng X; Song X; Lu Z; Jiang H; Liu L
    Tumour Biol; 2010 Aug; 31(4):287-95. PubMed ID: 20422343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.
    Okamoto K; Ocker M; Neureiter D; Dietze O; Zopf S; Hahn EG; Herold C
    J Cell Mol Med; 2007; 11(2):349-61. PubMed ID: 17378914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.
    Han Z; Lee S; Je S; Eom CY; Choi HJ; Song JJ; Kim JH
    Apoptosis; 2016 Mar; 21(3):351-64. PubMed ID: 26677013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
    Xia G; Wang H; Song Z; Meng Q; Huang X; Huang X
    J Exp Clin Cancer Res; 2017 Aug; 36(1):107. PubMed ID: 28797284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y; Liu H; Xue R; Tang W; Zhang S
    Dig Dis Sci; 2018 Dec; 63(12):3367-3375. PubMed ID: 30155839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma.
    Hii LW; Lim SE; Leong CO; Chin SY; Tan NP; Lai KS; Mai CW
    BMC Complement Altern Med; 2019 Sep; 19(1):257. PubMed ID: 31521140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells.
    Khanna A; Mahalingam K; Chakrabarti D; Periyasamy G
    Cell Mol Biol Lett; 2011 Mar; 16(1):101-13. PubMed ID: 21225469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition.
    Guo Q; Chen Y; Zhang B; Kang M; Xie Q; Wu Y
    Biochem Pharmacol; 2009 Jun; 77(11):1674-83. PubMed ID: 19428321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.
    Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
    Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    J Am Coll Surg; 2004 Jun; 198(6):953-9. PubMed ID: 15194078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
    Réjiba S; Wack S; Aprahamian M; Hajri A
    Cancer Sci; 2007 Jul; 98(7):1128-36. PubMed ID: 17489984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.